Skip to Main Content

Advertisement

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 131, Issue 3
January 18 2018
Issue Cover

Table of Contents

BLOOD COMMENTARIES

CLINICAL TRIALS AND OBSERVATIONS
Refining genetic stratification in T-ALL
Clinical Trials & Observations
David O’Connor
View Articletitled, Refining genetic stratification in T-ALL
GENE THERAPY
Editing gene engineering to enhance function
Emma C. Morris
View Articletitled, Editing gene engineering to enhance function
MYELOID NEOPLASIA
ASXL1 mutations gain a function
Toshio Kitamura
View Articletitled, <em>ASXL1</em> mutations gain a function
VASCULAR BIOLOGY
Prochemerin processing by factor XIa
Joost C. M. Meijers
View Articletitled, Prochemerin processing by factor XIa

REVIEW ARTICLE

Platelets and vascular integrity: how platelets prevent bleeding in inflammation
Benoit Ho-Tin-Noé,Yacine Boulaftali,Eric Camerer
View Articletitled, Platelets and vascular integrity: how platelets prevent bleeding in inflammation

CLINICAL TRIALS AND OBSERVATIONS

Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia
CME Clinical Trials & Observations
Arnaud Petit,Amélie Trinquand,Sylvie Chevret,Paola Ballerini,Jean-Michel Cayuela,Nathalie Grardel,Aurore Touzart,Benoit Brethon,Hélène Lapillonne,Claudine Schmitt,Sandrine Thouvenin,Gerard Michel,Claude Preudhomme,Jean Soulier,Judith Landman-Parker,Guy Leverger,Elizabeth Macintyre,André Baruchel,Vahid Asnafi,on behalf of the French Acute Lymphoblastic Leukemia Study Group (FRALLE)
View Articletitled, Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia
Supplemental data
Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma
Clinical Trials & Observations
Thierry Facon,Meletios A. Dimopoulos,Angela Dispenzieri,John V. Catalano,Andrew Belch,Michele Cavo,Antonello Pinto,Katja Weisel,Heinz Ludwig,Nizar J. Bahlis,Anne Banos,Mourad Tiab,Michel Delforge,Jamie D. Cavenagh,Catarina Geraldes,Je-Jung Lee,Christine Chen,Albert Oriol,Javier De La Rubia,Darrell White,Daniel Binder,Jin Lu,Kenneth C. Anderson,Philippe Moreau,Michel Attal,Aurore Perrot,Bertrand Arnulf,Lugui Qiu,Murielle Roussel,Eileen Boyle,Salomon Manier,Mohamad Mohty,Herve Avet-Loiseau,Xavier Leleu,Annette Ervin-Haynes,Guang Chen,Vanessa Houck,Lotfi Benboubker,Cyrille Hulin
View Articletitled, Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma
Supplemental data

GENE THERAPY

CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells
Mateusz Legut,Garry Dolton,Afsar Ali Mian,Oliver G. Ottmann,Andrew K. Sewell
View Articletitled, CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells
Supplemental data

HEMATOPOIESIS AND STEM CELLS

Smoothened signaling in the mouse osteoblastoid lineage is required for efficient B lymphopoiesis
Brief Report
Wenyan Lu,Dominic Dordai,David Huso,Stephen Desiderio
View Articletitled, Smoothened signaling in the mouse osteoblastoid lineage is required for efficient B lymphopoiesis
Supplemental data

MYELOID NEOPLASIA

Gain of function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies
Hui Yang,Stefan Kurtenbach,Ying Guo,Ines Lohse,Michael A. Durante,Jianping Li,Zhaomin Li,Hassan Al-Ali,Lingxiao Li,Zizhen Chen,Matthew G. Field,Peng Zhang,Shi Chen,Shohei Yamamoto,Zhuo Li,Yuan Zhou,Stephen D. Nimer,J. William Harbour,Claes Wahlestedt,Mingjiang Xu,Feng-Chun Yang
View Articletitled, Gain of function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

Ferritin is secreted via 2 distinct nonclassical vesicular pathways
Marianna Truman-Rosentsvit,Dina Berenbaum,Lior Spektor,Lyora A. Cohen,Shirly Belizowsky-Moshe,Lena Lifshitz,Jing Ma,Wei Li,Ellina Kesselman,Inbal Abutbul-Ionita,Dganit Danino,Lucia Gutierrez,Huihui Li,Kuanyu Li,Huifang Lou,Maria Regoni,Maura Poli,Fabian Glaser,Tracey A. Rouault,Esther G. Meyron-Holtz
View Articletitled, Ferritin is secreted via 2 distinct nonclassical vesicular pathways
Supplemental data

VASCULAR BIOLOGY

Prochemerin cleavage by factor XIa links coagulation and inflammation
Xiaomei Ge,Yasuto Yamaguchi,Lei Zhao,Loredana Bury,Paolo Gresele,Caroline Berube,Lawrence L. Leung,John Morser
View Articletitled, Prochemerin cleavage by factor XIa links coagulation and inflammation
Supplemental data

LETTERS TO BLOOD

Chronic lymphocytic leukemia international prognostic index: a systematic review and meta-analysis
Clinical Trials & Observations
Stefano Molica,Diana Giannarelli,Rosanna Mirabelli,Luciano Levato,Neil E. Kay,Tait D. Shanafelt
View Articletitled, Chronic lymphocytic leukemia international prognostic index: a systematic review and meta-analysis
Supplemental data
First report of ibrutinib in IgM-related amyloidosis: few responses, poor tolerability, and short survival
Clinical Trials & Observations
Tomas Pika,Ute Hegenbart,Pavla Flodrova,Bettina Maier,Christoph Kimmich,Stefan O. Schönland
View Articletitled, First report of ibrutinib in IgM-related amyloidosis: few responses, poor tolerability, and short survival

BLOOD WORK

Composite morphologically and immunohistochemically distinct classical and pleomorphic mantle cell lymphomas
Huan-You Wang,Richard L. Wong
View Articletitled, Composite morphologically and immunohistochemically distinct classical and pleomorphic mantle cell lymphomas

ERRATUM

Sood R, Kamikubo Y, Liu P. Role of RUNX1 in hematological malignancies. Blood. 2017;129(15):2070-2082.
View Articletitled, Sood R, Kamikubo Y, Liu P. Role of RUNX1 in hematological malignancies. <em>Blood.</em> 2017;129(15):2070-2082.

CONTINUING MEDICAL EDUCATION (CME) QUESTIONS

Oncogenetics and MRD in pediatric T-ALL
CME
View Articletitled, Oncogenetics and MRD in pediatric T-ALL
All Issues

Advertisement

Relating NF-κB regulation to MPN pathogenesis
The elusive endothelial iron transporter
AAV delivers as a lingering guest, not an invader
PCM1::JAK2 myeloproliferative neoplasm suggested by bone marrow histopathological features
Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice.

Advertisement

Advertisement

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement